NFI Group Inc. (TSE:NFI – Get Rating) has earned a consensus rating of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price objective among […]
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note published on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler restated a neutral rating on shares of Infinity Pharmaceuticals in a research note on Friday, February 24th. Infinity Pharmaceuticals Stock Performance NASDAQ:INFI […]
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a report released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reaffirmed a neutral rating on shares of Infinity Pharmaceuticals in a research note on Friday, February 24th. Infinity Pharmaceuticals Stock Up 7.1 % […]
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reissued a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Stock […]
NFI Group Inc. (TSE:NFI – Get Rating) – Equities research analysts at Atb Cap Markets lifted their Q2 2023 earnings per share estimates for shares of NFI Group in a report issued on Wednesday, May 17th. Atb Cap Markets analyst C. Murray now forecasts that the company will post earnings of ($0.72) per share for […]